Lumos Diagnostics
Point-of-Care Assays Services
Lumos manages the full development program for point-of-care (POC) assays, from sourcing and/or generation of reagents, right through to verification and validation. With the acquisition of Kestrel BioSciences, the Lumos team brings over 30 years of experience in lateral flow assay development and market knowledge.
Most popular related searches
Full Development Capabilities from Assay to Complete POC Device
The Lumos team has broad capability across the full spectrum of POC assay development needs including:
- Lateral flow, flow through and enzyme assays
- Visible and fluorescent detection chemistries
- Qualitative, semi-quantitative and quantitative formats
- Single and multi-plex
- Broad range of specimen types
- In-house OEM manufacturing
Development Process
Lumos assay development follows a standard phased approach, with a focus on reducing product risk and matching development effort with the appropriate regulatory requirements.
Lumos begins by working with its partners to obtain a thorough understanding of the customer and product needs, ensuring the key specifications and design elements are fully understood from both a scientific and market perspective.
Throughout the development program, our experienced project leaders will ensure clear communication of project progress and tracking against timelines and budget.
Lumos begins by working with its partners to obtain a thorough understanding of the customer and product needs, ensuring the key specifications and design elements are fully understood from both a scientific and market perspective.
Throughout the development program, our experienced project leaders will ensure clear communication of project progress and tracking against timelines and budget.